Category - Executive Moves

Executive Moves

Sernova names Frank Shannon as VP clinical development, regulatory affairs

Frank Shannon Sernova (TSXV:SVA; OTC:SEOVF; FSE/XETRA:PSH) appointed 25-year pharmaceutical industry executive, Frank Shannon, as VP of clinical development and regulatory Affairs. Mr. Shannon most recently served...

June 30, 2021

Executive Moves

Talkiatry names Jared Camins as CTO

Talkiatry appoints Jared Camins as Chief Technology Officer Closely-held Talkiatry, a leading mental health care provider that connects people with high-quality psychiatric care via telehealth or in-person, appointed...

June 22, 2021

Executive Moves

PharmaJet names Paul LaBarre as VP global business development

Paul LaBarre PharmaJet named Paul LaBarre as VP of global business development to lead business development and commercialization strategies, replacing Melissa Malhame, who transitioned to a strategic advisory role for...

June 15, 2021

Executive Moves

Accelmed Partners bolsters senior HealthTech executive team

Eric Tansky, former managing director in Oppenheimer’s medical technology practice, has joined Accelmed Partners, a private equity firm in HealthTech, as a general partner, and Stephen Rubin, former co-head of...

June 14, 2021

Executive Moves

iBio adds veteran biopharmaceutical executive Evert Schimmelpennink to board

Evert Schimmelpennink iBio (NYSEA:IBIO) appointed Evert (Eef) Schimmelpennink to its board of directors, effective immediately. In an executive leadership career spanning more than 20 years, Mr. Schimmelpennink has...

June 10, 2021

Executive Moves

RNA Disease Diagnostics adds John Erickson Jr. as president

John Erickson Jr. RNA Disease Diagnostics (RNADD) appointed John Erickson, Jr. to the newly created position of president to lead day-to-day operations. He will report directly to company co-founder and executive...

June 1, 2021

Executive Moves

Doug Kleinberg joins BTIG healthcare investment banking

Doug Kleinberg Doug Kleinberg has joined BTIG’s healthcare investment banking unit as a managing director to focus on investment banking opportunities for corporate clients across biotech, biopharma and pharma. Mr...

May 24, 2021

Executive Moves

Roth adds John Boris to healthcare investment banking team

John Boris John Boris has joined Roth Capital Partners’ healthcare investment banking team as a managing director. Prior to joining Roth, Mr. Boris was the managing partner of JTB Capital Management, where he invested...

May 19, 2021

Executive Moves

Ripple Therapeutics appoints renowned ophthalmologist Dr. Jonathan Talamo to board

Jonathan Talamo Closely-held Ripple Therapeutics named Jonathan Talamo, M.D., an internationally known ophthalmologist, innovator and consultant to the industry with more than 25 years of experience in healthcare, to...

May 4, 2021

Executive Moves

Former U.S. assistant secretary for health Admiral Joxel Garcia joins Flurotest advisory board

Admiral Joxel Garcia Former U.S. assistant secretary for health and four-star Admiral Joxel Garcia, M.D. joined FluroTest’s (TSXV:TEST; OTCQB:FLURF) advisory board. Dr. Garcia will help support FluroTest...

April 6, 2021

Category - Executive Moves

Sernova names Frank Shannon as VP clinical development, regulatory affairs

Talkiatry names Jared Camins as CTO

PharmaJet names Paul LaBarre as VP global business development

Accelmed Partners bolsters senior HealthTech executive team

iBio adds veteran biopharmaceutical executive Evert Schimmelpennink to board

RNA Disease Diagnostics adds John Erickson Jr. as president

Doug Kleinberg joins BTIG healthcare investment banking

Roth adds John Boris to healthcare investment banking team

Ripple Therapeutics appoints renowned ophthalmologist Dr. Jonathan Talamo to board

Former U.S. assistant secretary for health Admiral Joxel Garcia joins Flurotest advisory board

General

More